Bedaquiline Enhanced Post ExpOsure Prophylaxis for Leprosy (Phase 2)

Condition:   Leprosy Interventions:   Drug: BE-PEP (Bedaquiline);   Drug: SDR-PEP;   Drug: BE-PEP (Rifampicine) Sponsors:   Institute of Tropical Medicine, Belgium;   Damien Foundation Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials